ES2145425T3 - Comprimidos de valaciclovir que contienen dioxido de silicio coloidal. - Google Patents

Comprimidos de valaciclovir que contienen dioxido de silicio coloidal.

Info

Publication number
ES2145425T3
ES2145425T3 ES96900626T ES96900626T ES2145425T3 ES 2145425 T3 ES2145425 T3 ES 2145425T3 ES 96900626 T ES96900626 T ES 96900626T ES 96900626 T ES96900626 T ES 96900626T ES 2145425 T3 ES2145425 T3 ES 2145425T3
Authority
ES
Spain
Prior art keywords
silicon dioxide
tablets containing
valaciclovir
coloidal
valaciclovir tablets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96900626T
Other languages
English (en)
Spanish (es)
Inventor
Barry Howard Carter
Lloyd Gary Tillman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10768317&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2145425(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Application granted granted Critical
Publication of ES2145425T3 publication Critical patent/ES2145425T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ES96900626T 1995-01-20 1996-01-19 Comprimidos de valaciclovir que contienen dioxido de silicio coloidal. Expired - Lifetime ES2145425T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9501127.6A GB9501127D0 (en) 1995-01-20 1995-01-20 Tablet

Publications (1)

Publication Number Publication Date
ES2145425T3 true ES2145425T3 (es) 2000-07-01

Family

ID=10768317

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96900626T Expired - Lifetime ES2145425T3 (es) 1995-01-20 1996-01-19 Comprimidos de valaciclovir que contienen dioxido de silicio coloidal.

Country Status (38)

Country Link
US (1) US5879706A (OSRAM)
EP (1) EP0806943B1 (OSRAM)
JP (1) JP3350055B2 (OSRAM)
KR (1) KR100412298B1 (OSRAM)
CN (2) CN1131026C (OSRAM)
AP (1) AP666A (OSRAM)
AT (1) ATE190483T1 (OSRAM)
AU (1) AU710823B2 (OSRAM)
BG (1) BG63187B1 (OSRAM)
BR (1) BR9606769A (OSRAM)
CA (1) CA2210891C (OSRAM)
CY (1) CY2182B1 (OSRAM)
CZ (1) CZ296514B6 (OSRAM)
DE (1) DE69607146T2 (OSRAM)
DK (1) DK0806943T3 (OSRAM)
EA (1) EA000276B1 (OSRAM)
EE (1) EE03336B1 (OSRAM)
ES (1) ES2145425T3 (OSRAM)
FI (1) FI119722B (OSRAM)
GB (1) GB9501127D0 (OSRAM)
GE (1) GEP20022752B (OSRAM)
GR (1) GR3033677T3 (OSRAM)
HU (1) HU226131B1 (OSRAM)
IL (1) IL116830A (OSRAM)
IN (1) IN181318B (OSRAM)
MY (1) MY126346A (OSRAM)
NO (1) NO311488B1 (OSRAM)
NZ (1) NZ298846A (OSRAM)
OA (1) OA10500A (OSRAM)
PL (1) PL185307B1 (OSRAM)
PT (1) PT806943E (OSRAM)
RO (1) RO118175B1 (OSRAM)
SK (1) SK282030B6 (OSRAM)
TR (1) TR199700657T1 (OSRAM)
UA (1) UA68325C2 (OSRAM)
UY (2) UY25774A1 (OSRAM)
WO (1) WO1996022082A1 (OSRAM)
ZA (1) ZA96448B (OSRAM)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9501127D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Tablet
DK0874631T3 (da) * 1996-01-19 2004-03-22 Glaxo Group Ltd Anvendelse af valaciclovir til fremstilling af et medikament til behandling af genital herpes ved en enkelt daglig anvendelse
AR016827A1 (es) * 1997-08-22 2001-08-01 Smithkline Beecham Corp PROCEDIMIENTO PARA LA PREPARACIoN DE UNA TABLETA FARMACÉUTICA
AR017512A1 (es) * 1997-08-22 2001-09-12 Smithkline Beecham Corp Tabletas de metilcelulosa rapidamente desintegrables para administracion por via oral y procedimiento para prepararlas
EP1140034B1 (en) * 1998-12-18 2003-11-26 Abbott Laboratories Controlled release formulation of divalproex sodium
GB0010446D0 (en) * 2000-04-28 2000-06-14 Glaxo Wellcome Kk Pharmaceutical formulation
HRP20030858A2 (en) * 2001-05-01 2005-08-31 Pfizer Products Inc. Method for manufacturing a low dose pharmaceutical composition having uniform drug distribution and potency
US7815936B2 (en) * 2001-10-30 2010-10-19 Evonik Degussa Gmbh Use of granular materials based on pyrogenically produced silicon dioxide in pharmaceutical compositions
CA2465420A1 (en) * 2001-11-05 2003-05-15 Glaxo Group Limited Anhydrous crystal form of valaciclovir hydrochloride
US6849737B2 (en) * 2001-11-14 2005-02-01 Teva Pharmaceutical Industries Ltd. Synthesis and purification of valacyclovir
GB0203296D0 (en) * 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
EP1517678A2 (en) * 2002-06-24 2005-03-30 Ranbaxy Laboratories Limited Process for the preparation of robust formulations of valacyclovir hydrochloride tablets
US20050051922A1 (en) * 2002-09-20 2005-03-10 Avinash Nangia Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same
US20050070711A1 (en) * 2002-10-16 2005-03-31 Igor Lifshitz Method for reducing residual alcohols in crystalline valacyclovir hydrochloride
US20050059684A1 (en) * 2002-10-16 2005-03-17 Ben-Zion Dolitzky Method for reducing residual alcohols in crystalline valacyclovir hydrochloride
US20040109889A1 (en) * 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
EP1633753A1 (en) * 2003-05-30 2006-03-15 EOS Eczacibasi Ozgun Kimyasal Urunler Sanayi Ve Ti Caret A.S. Novel crystalline forms of valacyclovir hydrochloride
KR100871621B1 (ko) * 2003-06-02 2008-12-02 테바 파마슈티컬 인더스트리즈 리미티드 발라시클로비르 히드로클로라이드의 신규한 결정질 형태
US7632521B2 (en) * 2003-07-15 2009-12-15 Eurand, Inc. Controlled release potassium chloride tablets
DK3260117T3 (da) 2003-09-12 2019-07-01 Amgen Inc Hurtigt opløsende formulering, der omfatter cinacalcet-hcl
DE10351448A1 (de) * 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
ES2246034T3 (es) * 2003-12-09 2006-02-01 Helm Ag Formulacion farmaceutica de valaciclovir.
US7344907B2 (en) * 2004-11-19 2008-03-18 International Business Machines Corporation Apparatus and methods for encapsulating microelectromechanical (MEM) devices on a wafer scale
KR101116747B1 (ko) 2004-12-06 2012-02-22 에스케이케미칼주식회사 안정성이 개선된 말레인산 암로디핀 약제 조성물
US9737488B2 (en) 2005-03-07 2017-08-22 Bayer Healthcare Llc Pharmaceutical composition for the treatment of cancer
ATE546451T1 (de) * 2005-05-25 2012-03-15 Lilly Co Eli Cyclopropancarbonsäureester von acyclovir
EP1746098A1 (en) * 2005-07-21 2007-01-24 SOLMAG S.p.A. Valacyclovir polymorphs and a process for the preparation thereof
WO2007090595A1 (en) * 2006-02-06 2007-08-16 Fidia Pharmaceutici S.P.A. Solid formulations of valacyclovir hydrochloride
EP2023899A1 (en) * 2006-05-10 2009-02-18 Evonik Degussa GmbH Use of roll compacted pyrogenically produced silicon dioxide in pharmaceutical compositions
RU2446800C2 (ru) * 2006-05-31 2012-04-10 Вертекс Фармасьютикалз Инкорпорейтед Препаративные формы с контролируемым высвобождением
US20090291136A1 (en) * 2006-07-11 2009-11-26 Lek Pharmaceuticals D.D. Multiple Unit Tablets
US20080167325A1 (en) * 2006-12-27 2008-07-10 Bs Praveen Kumar Valacyclovir compositions
US20090076039A1 (en) * 2007-09-14 2009-03-19 Protia, Llc Deuterium-enriched valacyclovir
ITRM20080027A1 (it) * 2008-01-18 2009-07-19 Maria Balestrieri Uso di aciclovir per il trattamento delle condilomatosi.
US20100124560A1 (en) * 2008-11-14 2010-05-20 Mcneil Ab Multi portion intra-oral dosage form and use thereof
KR101665395B1 (ko) * 2009-03-13 2016-10-12 토야마 케미칼 컴퍼니 리미티드 6-플루오로-3-히드록시-2-피라진카르복사미드 함유 정제 및 조립분말
CH703348A1 (de) * 2010-06-29 2011-12-30 Mepha Gmbh Zusammensetzungen mit hohem Wirkstoffanteil an pharmazeutisch aktiven Substanzen.
GB2515486A (en) * 2013-06-24 2014-12-31 Kraft Foods R & D Inc Soluble Beverage Ingredients
KR101497508B1 (ko) * 2013-12-20 2015-03-03 한국유나이티드제약 주식회사 펠라고니움 시도이데스 추출물 및 규산 화합물을 포함하는 고형 제제 및 이의 제조 방법
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
WO2020049536A1 (en) * 2018-09-07 2020-03-12 Jubilant Generics Limited Pharmaceutical compositions of valacyclovir or its pharmaceutically acceptable salts thereof
CN110279667B (zh) * 2019-07-30 2023-02-10 珠海润都制药股份有限公司 一种盐酸伐昔洛韦片及其制备方法
CN115666516A (zh) * 2020-06-01 2023-01-31 希尔帕医疗保健有限公司 包括卡培他滨的快速分散药物组合物
WO2022119270A1 (ko) * 2020-12-01 2022-06-09 주식회사 엘지화학 1-(3-시아노-1-아이소프로필-인돌-5-일)피라졸-4-카르복실산을 포함하는 경구용 제제, 및 그의 제조방법
CA3266275A1 (en) * 2022-08-31 2024-03-07 Astrazeneca Ab PHARMACEUTICAL FORMULATION

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1259924A (en) * 1985-03-25 1989-09-26 Wallace E. Becker Pharmaceutical tableting method
AP55A (en) * 1987-08-15 1989-09-26 The Wellcome Foundation Ltd Therapeutic Acyclic Nucleosides
DE68903605T2 (de) * 1988-05-04 1993-04-01 Smith Kline French Lab Kautablette.
DE69207656T2 (de) * 1991-01-30 1996-10-17 The Wellcome Foundation Ltd., London Wasserlösliche tabletten
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
GB9317146D0 (en) * 1993-08-18 1993-10-06 Wellcome Found Therapeutic combinations
GB9501127D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Tablet

Also Published As

Publication number Publication date
CY2182B1 (en) 2002-08-23
EP0806943A1 (en) 1997-11-19
GR3033677T3 (en) 2000-10-31
MY126346A (en) 2006-09-29
AU4453496A (en) 1996-08-07
CZ296514B6 (cs) 2006-03-15
WO1996022082A1 (en) 1996-07-25
NZ298846A (en) 1998-06-26
HU226131B1 (en) 2008-05-28
JP3350055B2 (ja) 2002-11-25
MX9705459A (es) 1997-10-31
TR199700657T1 (xx) 1998-02-21
HK1002851A1 (en) 1998-09-25
BG63187B1 (bg) 2001-06-29
OA10500A (en) 2002-04-10
EA000276B1 (ru) 1999-02-25
BG101831A (en) 1998-04-30
NO973327L (no) 1997-09-16
FI119722B (fi) 2009-02-27
AU710823B2 (en) 1999-09-30
KR100412298B1 (ko) 2004-04-21
JPH10512564A (ja) 1998-12-02
EP0806943B1 (en) 2000-03-15
IL116830A (en) 2000-02-29
GEP20022752B (en) 2002-08-26
NO311488B1 (no) 2001-12-03
KR19980701524A (ko) 1998-05-15
CZ229297A3 (cs) 1998-02-18
FI973062A0 (fi) 1997-07-18
SK282030B6 (sk) 2001-10-08
IL116830A0 (en) 1996-05-14
CN1313081C (zh) 2007-05-02
UY25774A1 (es) 2000-10-31
US5879706A (en) 1999-03-09
CA2210891A1 (en) 1996-07-25
CN1131026C (zh) 2003-12-17
DE69607146T2 (de) 2000-09-21
BR9606769A (pt) 1997-12-30
PL185307B1 (pl) 2003-04-30
EA199700123A1 (ru) 1997-12-30
ZA96448B (en) 1996-08-07
GB9501127D0 (en) 1995-03-08
RO118175B1 (ro) 2003-03-28
NO973327D0 (no) 1997-07-18
UY25778A1 (es) 2000-08-21
AP666A (en) 1998-08-24
HUP9801872A3 (en) 2001-02-28
HUP9801872A2 (hu) 1999-10-28
EE03336B1 (et) 2001-02-15
CN1494898A (zh) 2004-05-12
IN181318B (OSRAM) 1998-05-09
DK0806943T3 (da) 2000-07-24
PL321361A1 (en) 1997-12-08
PT806943E (pt) 2000-08-31
ATE190483T1 (de) 2000-04-15
AP9701057A0 (en) 1997-10-31
DE69607146D1 (de) 2000-04-20
UA68325C2 (en) 2004-08-16
SK96497A3 (en) 1998-01-14
CN1179100A (zh) 1998-04-15
CA2210891C (en) 2009-05-19
FI973062L (fi) 1997-09-18

Similar Documents

Publication Publication Date Title
ES2145425T3 (es) Comprimidos de valaciclovir que contienen dioxido de silicio coloidal.
BR9807742A (pt) EpotilÈneos que são modificados na cadeia lateral
TW200502367A (en) Liquid-crystalline medium
DK0817847T4 (da) IL-17-receptor
HN1998000175A (es) Imidazotriazininas
ITMI931780A1 (it) Tropil 7-azaindolil-3-carbossiamidi
NO976048L (no) Farmasöytiske og diett formuleringer for profylakse og behandling av mave- og tarmforstyrrelser
TR200200644T2 (tr) Dallandırılmış polikarbonat konteynerleri.
DK0700380T3 (da) N-Alkylthiopolyaminderivater som radioprotektive midler
NO962459L (no) Stabilisert vinylkloridsammensetning
ZA961364B (en) 1-Aryl-2-acylamino-ethane compounds
GR3036142T3 (en) Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents
ITBO940054A0 (it) Linea di impacchettamento per la formazione di pacchetti "twin".
ES2173556T3 (es) Nuevos compuestos heterociclicos, su procedimiento de preparacion y los compuestos farmaceuticos que los contienen.
PL352104A1 (en) Oral composition containing perlite
DE69316200D1 (de) Feuchtigkeitsspender
MA26980A1 (fr) Antagonistes des recepteurs d'histamine.
DE69614552D1 (de) MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE
NO943336D0 (no) Chinolinforbindelser
FR2860436B1 (fr) Nouvelle association d'un anti-atherothrombotique et d'un antiagregant plaquettaire
ES2184025T3 (es) Estante.
DE59810106D1 (de) Substituierte 2,4-diamino-1,3,5-triazine
ES2182587T3 (es) Utilizacion de aleaciones de zinc.
UA30250A (uk) Антиоксидантний засіб
HN1997000108A (es) Derivado 6,6,6.6.7- biciclicas sustituido que contiene pirido o pirimido

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 806943

Country of ref document: ES